WELL Health Technologies Achieves Record Q3-2025 Financial Results

An update from WELL Health Technologies Corp ( (TSE:WELL) ) is now available.

WELL Health Technologies Corp reported record financial results for Q3-2025, with revenues reaching $364.6 million, a 56% increase from the previous year, driven by organic growth and acquisitions. The company achieved a record Adjusted EBITDA of $59.9 million, marking a 296% increase, and highlighted improvements in operational efficiency and patient visits in its Canadian clinics. WELLSTAR, a majority-owned subsidiary, secured $62 million in financing, reflecting strong market confidence and positioning it for future growth and an IPO.

The most recent analyst rating on (TSE:WELL) stock is a Hold with a C$6.00 price target. To see the full list of analyst forecasts on WELL Health Technologies Corp stock, see the TSE:WELL Stock Forecast page.

Spark’s Take on TSE:WELL Stock

According to Spark, TipRanks’ AI Analyst, TSE:WELL is a Neutral.

The overall stock score is primarily influenced by the company’s strong revenue growth, which is offset by significant challenges in profitability and cash flow management. Technical analysis suggests mixed signals, with potential for a longer-term uptrend despite short-term bearish momentum. The valuation is negatively impacted by the company’s unprofitability and lack of dividend yield.

To see Spark’s full report on TSE:WELL stock, click here.

More about WELL Health Technologies Corp

WELL Health Technologies Corp is a digital healthcare company focused on improving health outcomes through technology, empowering healthcare practitioners and patients globally.

Average Trading Volume: 1,225,780

Technical Sentiment Signal: Strong Buy

Current Market Cap: C$1.26B

For detailed information about WELL stock, go to TipRanks’ Stock Analysis page.